CITY TESTING CENTERS LLC
NPI 1265184584
Clinical Medical Laboratory in New York, NY

NPI Status: Active since January 19, 2022

Contact Information

165 BROADWAY FL 23
NEW YORK, NY
ZIP 10006
Phone: (716) 214-0498

NPI Profile Information
Primary Taxonomy
Authorized Official
Areas of Expertise
CLIA Information
NPI Validation
Other Providers Same Location
Frequently Asked Questions

Organization
Clinical Medical Laboratory
CLIA Number: 33D2256067
CLIA Cert. Type: Independent
CLIA Exp. Date: 03-26-2027

About CITY TESTING CENTERS LLC

This page provides the complete NPI Profile along with additional information for City Testing Centers Llc, a provider established in New York, New York operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1265184584 assigned on January 2022. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 3 years ago. The authorized official of this NPI record is Mr. David M Carr (Owner)

NPI: 1265184584
Provider Name: CITY TESTING CENTERS LLC
Entity Type: Organization
Location Address: 165 BROADWAY FL 23 NEW YORK, NY 10006
Location Phone: (716) 214-0498
Mailing Address: 165 BROADWAY FL 23 NEW YORK, NY 10006
Is Sole Proprietor?: No
Is Organization Subpart?: No
Enumeration Date: 01-19-2022
Last Update Date: 06-15-2022
Code Navigator

Establishments like City Testing Centers Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification: Clinical Medical Laboratory
Taxonomy Code: 291U00000X
Type: Laboratories
Taxonomy Description: (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name: MR. DAVID M CARR
Authorized Official Title: OWNER
Authorized Official Phone: (917) 515-7500

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number: 33D2256067
Facility Type: Independent
Certificate Effective Date: March 21, 2022
Certificate Expiration Date: March 26, 2027
Laboratory Director: MS. CANDICE P. LYKE-FRAZIER
Certificate Type: Certificate of Waiver
Certificate Type Description: This CLIA certificate is issued to City Testing Centers Llc to perform only waived tests. CLIA defines waived tests as simple tests with a low risk for an incorrect result. Waived tests include certain tests listed in CLIA regulations, tests cleared by the FDA for home use and tests approved by the FDA for waived status and that meet CLIA waiver criteria.

NPI Validation Check Digit Calculation

The following table explains the step by step NPI number validation process using the ISO standard Luhn algorithm.

Start with the original NPI number, the last digit is the check digit and is not used in the calculation.
1	2	6	5	1	8	4	5	8	4
Step 1: Double the value of the alternate digits, beginning with the rightmost digit.
2	2	12	5	2	8	8	5	16
Step 2: Add all the doubled and unaffected individual digits from step 1 plus the constant number 24.
2 + 2 + 1 + 2 + 5 + 2 + 8 + 8 + 5 + 1 + 6 + 24 = 66
Step 3: Subtract the total obtained in step 2 from the next higher number ending in zero, the result is the check digit.
70 - 66 = 4									4

The NPI number 1265184584 is valid because the calculated check digit 4 using the Luhn validation algorithm matches the last digit of the original NPI number.